photo of a green light on a stoplight
Pharma

Inovio wins FDA nod for DNA-based immunotherapy in rare disease

Inovio’s Voceryq, approved for a rare HPV-driven disease, represents the first plasmid DNA-based immunotherapy in the U.S.
Angus Liu Nov 2, 2026 10:53am
Resource Icon
The direct-to-patient DTP market is full of providers making bold claims But claims are not outcomes To unlock the true p

DTP – Delivering Proof Over Promise

Brought to you by Gifthealth
bid

Karyopharm files Chapter 11 ahead of Ayrmid merger

Nov 2, 2026 10:46am
Graphic image of a compass above an unfolded map Orange background color

Compass points to unmet need as psychedelic nears market

Nov 2, 2026 10:33am
Handshake MA

Fresenius targets €370B originator market with WuXi biosim deal

Nov 2, 2026 9:43am
dupixent

Sanofi tips Dupixent to reap rewards from Lilly’s Ebglyss ads

Nov 2, 2026 2:27am
More News

Regulatory tracker: Ilumya's expansion; Bayer gets 1st FXIa nod

Oct 30, 2026 3:41pm

AbbVie touts robust Q3 as analysts query growth past immunology

Oct 30, 2026 3:15pm

The Oral GLP-1 Tracker: Scripts rise for Foundayo, Wegovy pill

Oct 30, 2026 2:40pm

Amid Dupixent boom, Sanofi looks hard at its R&D future

Oct 30, 2026 11:50am